Cardiovascular Disease in Inflammatory Arthritis:
Getting to the Heart of the Matter
The Effect of Cytokines and Remittive
Therapy for Inflammatory Arthritis
on Cardiovascular Outcomes
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Release Date: July 17, 2009
Expiration Date: July 17, 2011
Estimated Time of Completion: 30 minutes
Description
The Cardiovascular Disease in Inflammatory Arthritis: Getting to the Heart of the Matter Symposium held on May 6, 2009 in Cleveland, Ohio, was captured and repurposed into a webcast series. This educational activity is designed to increase practitioners’ knowledge of the biology and management strategies of cardiovascular disease associated with inflammatory arthritis, with the ultimate goal of improving the care of these patients.
Objectives
At the conclusion of this activity, the participant will be able to:
- Describe the role of proinflammatory cytokines in the pathogenesis of rheumatoid arthritis.
- Summarize the data linking RA to CV outcomes.
- Identify the effect of RA therapies on the morbidity and mortality associated with CV disease.
Target Audience
This activity is designed to increase rheumatologists’, cardiologists’, and other interested healthcare professionals’ knowledge of the biology and management strategies of cardiovascular disease associated with inflammatory arthritis, with the ultimate goal of improving the care of these patients.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the
Accreditation Council for Continuing Medical Education to provide continuing medical
education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Co Activity DirectorsFaculty
| Josef Smolen, MD Professor of Medicine and Chairman Division of Rheumatology Internal Medicine III Medical University of Vienna Vienna, Austria |
Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation
Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation
Center for Continuing Education requires resolution of all faculty conflicts of interest to
ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Leonard Calabrese, DO | |||
| Consulting: | Elan; Roche | ||
| Consulting, Teaching & Speaking: | Abbott; Amgen; Centocor; Genentech; Wyeth | ||
| Josef Smolen, MD | |||
| Consulting: | Abbott; Amgen; UCB | ||
| Membership on Advisory Committee/Review Panels: |
Abbott; Amgen; AstraZeneca; Centocor; Novartis; Pfizer; Roche; Schering-Plough; UCB; Wyeth | ||
| Research, Teaching & Speaking: | Abbott; Centocor; Roche; Schering-Plough; UCB; Wyeth | ||
The following faculty has indicated he/she has no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Elaine Husni, MD, MPH
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges an educational grant for support of this activity from:
Roche
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education and UNITECH Communications®.
